The Role of Surgery in Patients with COVID-19-Related Thoracic Complications

Raveglia, Federico; Scarci, Marco; Rimessi, Arianna; Orlandi, Riccardo; Rebora, Paola; Cioffi, Ugo; Guttadauro, Angelo; Ruffini, Enrico; Benvenuti, Mauro Roberto; Cardillo, Giuseppe; Patrini, Davide; Vannucci, Fernando; Yusuf, Nasser; Jindal, Pramoj; Cerfolio, Robert J.

doi:10.3389/fsurg.2022.867252

Cited by 3 publications

(1 citation statement)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, the risk of perioperative death increased further for this patient, due to SARS-Cov-2 infection. Among seropositive patients surgically treated for SARS-CoV-2 lung complications, high-risk score [3] and thoracotomy [11] were associated with higher mortality in previous reports, and these conditions were both present in our patient. Furthermore, Gonfiotti et al described a postoperative morbidity of 60% and a mortality of 40%, among five patients who underwent anatomic lung resection for cancer, while being SARS-CoV-2 positive [12].…”

Section: Discussionsupporting

confidence: 64%

Perioperative Management of a Patient With Multiple Comorbidities Undergoing Lung Resection for Bronchopulmonary Carcinoid Complicated by SARS-CoV-2 Infection: A Case Report

Sarridou,

Konstantinidou,

Boutou

et al. 2024

Cureus

View full text Add to dashboard Cite

We report a case of a high-risk patient with multiple comorbidities who underwent right median lobectomy and lymph node resection due to a carcinoid tumor. The patient’s course was complicated by a hospital-acquired severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and a postoperative chest hematoma requiring urgent thoracotomy. Multidisciplinary and timely management resulted in a favorable patient outcome.

show abstract

Section: Discussionsupporting

confidence: 64%

Perioperative Management of a Patient With Multiple Comorbidities Undergoing Lung Resection for Bronchopulmonary Carcinoid Complicated by SARS-CoV-2 Infection: A Case Report

Sarridou,

Konstantinidou,

Boutou

et al. 2024

Cureus

View full text Add to dashboard Cite

show abstract

ERS International Congress 2022: highlights from the Thoracic Surgery and Lung Transplantation Assembly

et al. 2023

View full text Add to dashboard Cite

The thoracic surgery and lung transplantation assembly (Assembly 8) of the European Respiratory Society (ERS) is delighted to present the highlights from the 2022 ERS International Congress that took place in a hybrid version in Barcelona, Spain. We have selected the four main sessions that discussed recent advances across a wide range of topics including the effects of COVID-19 on thoracic surgery and the challenges regarding lung transplantation in connective tissue diseases and common variable immunodeficiency (CVID). The sessions are summarised by early career members in close collaboration with the assembly faculty. We aim to provide the reader with an update and enhanced insight into the highlights of the conference in the fields of thoracic surgery and lung transplantation.

show abstract

Outcomes of patients with COVID-19 pneumonia requiring lung resections in a third-level hospital

Sánchez-Pereda,

Gomez-Portugal,

Canto-Losa

et al. 2024

Egypt J Bronchol

View full text Add to dashboard Cite

Introduction Currently, there is little evidence on the surgical management of pulmonary complications of COVID-19 pneumonia. This study aimed to give insight into common complications arising in patients with COVID-19 pneumonia that require lung resections. Methods This is a retrospective single-center study looking at conditions arising in patients with COVID-19 pneumonia who required lung resection for resolution between March 2020 and March 2021. Clinical presentation, indications to undergo surgery, and factors associated with increased mortality were analyzed. Analysis of nominal variables was performed using nonparametric statistical tests. Results Twelve men (92.3%) and one woman (7.7%) were included in the analysis; the age of included participants ranged from 27 to 72 years, with the mean age being 52. The most common presenting signs and symptoms were dyspnea and tachypnea, which were present in all patients, most common cause for surgery was pneumatocele with 6 cases, followed by lung abscess; patients who underwent surgery because of persistent air leak were more likely to require surgical reintervention (p = 0.005). The overall mortality in our sample was 23%. Increasing age (p = 0.014), myalgias (p = 0.035), elevated D-dimer (p = 0.007), and pulmonary embolism (p = 0.014) were associated with increased mortality. Conclusions Lung resections to treat pulmonary complications in patients with COVID-19 pneumonia appear to be safe, with a survival rate of 77%. Recognizing clinical characteristics such as age, myalgias, elevated D-dimer and pulmonary embolism can aid in identifying those at increased risk.

show abstract

The Role of Surgery in Patients with COVID-19-Related Thoracic Complications

Cited by 3 publications

References 36 publications

Perioperative Management of a Patient With Multiple Comorbidities Undergoing Lung Resection for Bronchopulmonary Carcinoid Complicated by SARS-CoV-2 Infection: A Case Report

Perioperative Management of a Patient With Multiple Comorbidities Undergoing Lung Resection for Bronchopulmonary Carcinoid Complicated by SARS-CoV-2 Infection: A Case Report

ERS International Congress 2022: highlights from the Thoracic Surgery and Lung Transplantation Assembly

Outcomes of patients with COVID-19 pneumonia requiring lung resections in a third-level hospital

Contact Info

Product

Resources

About